In relation to a recently published case [13] of a patient diagnosed with serous ovarian cancer which began as a paraneoplastic neurological syndrome, myasthenia gravis, here the importance of an early diagnosis of this type and its multidisciplinary handling is discussed. We want to highlight the early identification of the primary tumor and its treatment, in order to avoid the progression of these disorders which can develop into severe, incapacitating, or even fatal, neurological impairments. Keywords: Paraneoplastic Neurological Syndromes; Myasthenia gravis; Ovarian Cancer; Gynecological cance
Paraneoplastic syndromes are a heterogeneous group of clinical and biological manifestations caused ...
Neurological paraneoplastic syndromes (NPS) belong to a heterogeneous group of disorders affecting t...
Background: Paraneoplastic neurological syndromes (PNS) almost invariably predate detection of the m...
We describe the first case of myasthenia gravis as a possible paraneoplastic manifestation of ovaria...
Paraneoplastic neurological syndrome (PNS) is a neuropathological disorder of central nervous system...
Introduction: Paraneoplastic neurological syndromes (PNS) are neurologic deficits triggered by an un...
Paraneoplastic neurologic disorders can affect any part of the nervous system. Rarely, the motor neu...
10Paraneoplastic neurological syndromes (PNS) are remote effects of cancer on the nervous system. An...
Abstract Paraneoplastic neurological syndromes (PNS) can be defined as remote effects of cancer that...
Weakness, sensory loss, and paresthesias are common nonspecific symptoms, but can be important indic...
Myasthenia gravis (MG) and paraneoplastic cerebellar degeneration (PCD) are immune-mediated syndrome...
BACKGROUND: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and ex...
During the last 50 years it has become clear that malignant tumours can induce symptoms unrelated to...
8nonenoneLorusso L; Giometto B; Pezzani R; Ngonga G; Ferrari D; Ricevuti G; Broome J; Hart IKLorusso...
Neuro-ophthalmic consequences of paraneoplasia may involve multiple aspects of the afferent visual p...
Paraneoplastic syndromes are a heterogeneous group of clinical and biological manifestations caused ...
Neurological paraneoplastic syndromes (NPS) belong to a heterogeneous group of disorders affecting t...
Background: Paraneoplastic neurological syndromes (PNS) almost invariably predate detection of the m...
We describe the first case of myasthenia gravis as a possible paraneoplastic manifestation of ovaria...
Paraneoplastic neurological syndrome (PNS) is a neuropathological disorder of central nervous system...
Introduction: Paraneoplastic neurological syndromes (PNS) are neurologic deficits triggered by an un...
Paraneoplastic neurologic disorders can affect any part of the nervous system. Rarely, the motor neu...
10Paraneoplastic neurological syndromes (PNS) are remote effects of cancer on the nervous system. An...
Abstract Paraneoplastic neurological syndromes (PNS) can be defined as remote effects of cancer that...
Weakness, sensory loss, and paresthesias are common nonspecific symptoms, but can be important indic...
Myasthenia gravis (MG) and paraneoplastic cerebellar degeneration (PCD) are immune-mediated syndrome...
BACKGROUND: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and ex...
During the last 50 years it has become clear that malignant tumours can induce symptoms unrelated to...
8nonenoneLorusso L; Giometto B; Pezzani R; Ngonga G; Ferrari D; Ricevuti G; Broome J; Hart IKLorusso...
Neuro-ophthalmic consequences of paraneoplasia may involve multiple aspects of the afferent visual p...
Paraneoplastic syndromes are a heterogeneous group of clinical and biological manifestations caused ...
Neurological paraneoplastic syndromes (NPS) belong to a heterogeneous group of disorders affecting t...
Background: Paraneoplastic neurological syndromes (PNS) almost invariably predate detection of the m...